Latest News about FDA
Recent news which mentions FDA
After FDA Delays Hemophilia Gene Therapy, BioMarin's Dwarfism Drug Under FDA Review For Expanded Use
March 08, 2023
From Benzinga
Mesoblast's Lead Drug Candidate Goes Under FDA Priority Review For Bone Marrow Transplant Complications In Kids
March 08, 2023
Tickers
MESO
From Benzinga
From Benzinga
FDA's Regulatory Delay is The Reason For Novavax, Lucira Health's Failure: WSJ Report
March 07, 2023
From Benzinga
From Benzinga
Despite Trial Failure Praxis Still Seeks Advancing Essential Tremor Program Into Phase 3 Study
March 03, 2023
Tickers
PRAX
From Benzinga
FDA Fuels Respiratory Syncytial Virus Vaccine Race While Backing GSK's Candidate Soon After Pfizer's
March 02, 2023
From Benzinga
FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug'
March 01, 2023
From Benzinga
FDA Rejects Cytokinetics' Heart Failure Treatment Candidate
March 01, 2023
Tickers
CYTK
From Benzinga
FDA Approves Regeneron-Sanofi's Sarilumab As First Biologic For Stiffness, Pain In Muscles
March 01, 2023
From Benzinga
Reata Pharmaceuticals Gets Price Target Bumps By Analysts Following FDA Approval Of Skyclarys
March 01, 2023
Tickers
RETA
From Benzinga
Why Reata Pharmaceuticals Shares Are Falling Monday?
February 27, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.